MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases

TPN Nguyen, M Kumar, E Fedele, G Bonanno… - International journal of …, 2022 - mdpi.com
MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various
neuronal and non-neuronal cell functions and play a key role in pathological conditions …

The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury

ME Huibregtse, JJ Bazarian, SR Shultz… - … & Biobehavioral Reviews, 2021 - Elsevier
Abstract HUIBREGTSE, ME, Bazarian, JJ, Shultz, SR, and Kawata K. The biological
significance and clinical utility of emerging blood biomarkers for traumatic brain injury …

Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis

I Magen, NS Yacovzada, E Yanowski… - Nature …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative disease of the human
motor neuron system, where variability in progression rate limits clinical trial efficacy …

Skeletal muscle in amyotrophic lateral sclerosis

JM Shefner, A Musaro, ST Ngo, C Lunetta, FJ Steyn… - Brain, 2023 - academic.oup.com
Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been
viewed almost exclusively as a disease of upper and lower motor neurons, with muscle …

[HTML][HTML] miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis

SA Banack, RA Dunlop, EW Stommel, P Mehta… - Journal of the …, 2022 - Elsevier
Background and objectives We examined miRNA biomarkers for ALS extracted from
extracellular vesicles in blood samples using a large and diverse patient and control …

Dysregulated miRNAs as biomarkers and therapeutical targets in neurodegenerative diseases

G Gentile, G Morello, V La Cognata… - Journal of Personalized …, 2022 - mdpi.com
Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis
(ALS) are representative neurodegenerative diseases (NDs) characterized by degeneration …

Skeletal muscle in ALS: an unappreciated therapeutic opportunity?

S Scaricamazza, I Salvatori, A Ferri, C Valle - Cells, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the
selective degeneration of upper and lower motor neurons and by the progressive weakness …

RNA deregulation in amyotrophic lateral sclerosis: the noncoding perspective

P Laneve, P Tollis, E Caffarelli - International journal of molecular …, 2021 - mdpi.com
RNA metabolism is central to cellular physiopathology. Almost all the molecular pathways
underpinning biological processes are affected by the events governing the RNA life cycle …

MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease

Y Liu, Y Xu, M Yu - Experimental and therapeutic …, 2022 - spandidos-publications.com
The aim of the present study was to investigate the expression levels of microRNA (miR)‑
4722‑5p and miR‑615‑3p in Alzheimer's disease (AD) and their diagnostic value. Blood …

Deregulation of ncRNA in neurodegenerative disease: Focus on circRNA, lncRNA and miRNA in amyotrophic lateral sclerosis

P Ruffo, C Strafella, R Cascella, V Caputo… - Frontiers in …, 2021 - frontiersin.org
Parallel and massive sequencing of total RNA samples derived from different samples are
possible thanks to the use of NGS (Next Generation Sequencing) technologies. This allowed …